Femasys Corporation (FEMY) - התחייבויות לטווח ארוך להון

Femasys Inc. is implementing an affordable alternative to IVF through the FemaSeed system, although high marketing costs and regulatory complexities are limiting profits. The long-term debt financial leverage metric on GURU.Markets shows a current value of 1.00, allowing for the tracking of credit dependence. The team relies on the expertise of bioengineers attracted by a strong mission in women's health and the scientific environment.

Femasys Inc. management is actively investing in bringing innovative women's health systems to market. This metric compares liabilities with a maturity of more than one year to equity, measuring the company's financial leverage. An increase in this value signals aggressive expansion financing or the risk of overleveraged liabilities. It is critical for investors to assess the stability of the capital structure during periods of regulatory approvals. Analyzing the long-term debt-to-equity ratio allows for the verification of the issuer's development strategy.